Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes.

Item

http://www.wikidata.org/entity/Q38160494

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Refocusing Peroxisome Prolifer ...... Therapeutic Roles in Diabetes.

@en

type

Item

label

Refocusing Peroxisome Prolifer ...... Therapeutic Roles in Diabetes.

@en

prefLabel

Refocusing Peroxisome Prolifer ...... Therapeutic Roles in Diabetes.

@en

P1476

Refocusing Peroxisome Prolifer ...... Therapeutic Roles in Diabetes.

@en

P2093

Bong Soo Cha

http://www.w3.org/2001/XMLSchema#string

Hannah Seok

http://www.w3.org/2001/XMLSchema#string

P2860

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

Medical significance of peroxisome proliferator-activated receptors.

P304

326-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4093/DMJ.2013.37.5.326

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258337812

http://www.w3.org/2001/XMLSchema#string

P698

24199160

http://www.w3.org/2001/XMLSchema#string

P932

3816132

http://www.w3.org/2001/XMLSchema#string